Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Recent developments in the pathophysiology of bladder cancer

T A Rozanski1, H B Grossman

  • 1Department of Surgery, University of Michigan, Ann Arbor 48109-0030.

AJR. American Journal of Roentgenology
|October 1, 1994
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

New treatment approaches for superficial and invasive bladder cancer.

Urologic oncology·2011
Same author

Markers of bladder cancer State of the art.

Urologic oncology·2011
Same author

Prognostic significance of DNA ploidy in Ta/Tl bladder cancer: A southwest oncology group study.

Urologic oncology·2011
Same author

Burkitt's lymphoma of the testis.

Military medicine·2010
Same author

Bladder cancer markers in patient management: the current perspective.

World journal of urology·2007
Same author

High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk.

Carcinogenesis·2007

Transitional cell carcinoma (TCC) is the most common bladder cancer. Understanding TCC pathophysiology is crucial for developing new diagnostic and therapeutic strategies for this widespread urinary tract malignancy.

Area of Science:

  • Urology
  • Oncology
  • Pathophysiology

Background:

  • Bladder cancer is the most common urinary tract malignancy.
  • Transitional cell carcinoma (TCC) comprises over 90% of bladder tumors.
  • Bladder cancer accounts for a significant percentage of cancer deaths in the US.

Purpose of the Study:

  • To summarize new concepts in bladder cancer pathophysiology.
  • To focus on transitional cell carcinoma (TCC), the predominant histologic type.
  • To highlight advancements in understanding TCC behavior and progression.

Main Methods:

  • Review of current basic and clinical research.
  • Analysis of epidemiological data on bladder cancer incidence and mortality.
  • Focus on the natural history and behavior patterns of TCC.

Related Experiment Videos

Main Results:

  • TCC exhibits heterogeneous behavior with variable natural history.
  • Superficial papillary lesions represent 70-80% of initial diagnoses.
  • 20% of cases are diagnosed as invasive disease, with a high risk of progression and mortality.

Conclusions:

  • A better understanding of TCC pathophysiology is emerging from ongoing research.
  • New diagnostic and therapeutic strategies are being developed.
  • Effective management of invasive TCC remains a significant challenge, with high mortality rates.